| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Australia | 3 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Singapore | 2 | |
| #6 | Brazil | 1 | |
| #7 | China | 1 | |
| #8 | Israel | 1 | |
| #9 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Abel Tobias | 15 |
| #2 | Gertner-Dardenne Julie | 12 |
| #3 | Meyer François | 7 |
| #4 | Fenard David | 7 |
| #5 | Meyer Francois | 5 |
| #6 | Tobias Abel | 2 |
| #7 | Levings Megan | 1 |
| #8 | Dawson Nicolas | 1 |
| #9 | Julie Gertner-Dardenne | 1 |
| #10 | Megan Levings | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021028359A1 | Controlled expression of chimeric antigen receptors in t cells | |
| EP3808766A1 | Chimeric antigen receptor specific for interleukin-23 receptor | |
| CA3109253A1 | New car constructs comprising tnfr2 domains | |
| CA3096500A1 | Chimeric antigen receptor specific for interleukin-23 receptor |